Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Speechly Bircham
Speechly Bircham
Activities:
Regulatory
Patient Experience
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Schenck Process FPM becomes Coperion
Effective August 1, 2024, the company will officially transition its name under Coperion, whilst also providing more resources and broader technology capabilities to customers
Torbay Pharma strengthens leadership team to support North American growth strategy
The company has welcomed Mohammed Nazir as Chief Operating Officer (COO) and Tara Slivey as Chief Product Officer (CPO)
Ingenza expands codABLE gene design algorithm to aid recombinant protein production in yeast
The codABLE platform can help to accelerate the development and production of proteins in yeast hosts
DevPro Biopharma and Bespak complete early studies for novel sustainable albuterol inhaler
The novel formulation exhibits a low global warming potential (GWP) and shows comparable performance to Ventolin HFA
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Competition Law is catching pharma companies out
With major multinationals paying a high price for illegal and corrupt market activities, Paul Henty and Rory Ashmore, of legal firm Speechly Bircham, review the underlying causes and the risks
Subscribe now